Status:
COMPLETED
Effectiveness and Safety of Lidocaine for Scleroderma
Lead Sponsor:
Federal University of São Paulo
Conditions:
Scleroderma
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. The disease is characterized by thickening and fibrosis ski...
Eligibility Criteria
Inclusion
- Scleroderma (diffuse or limited) at less than 5 years of the first symptom
Exclusion
- Overlap with other connective tissue diseases
- Fibromyalgia
- Pregnancy
- Current use of ciclofosfamide ou D-penicillamine
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00740285
Start Date
April 1 2004
End Date
April 1 2007
Last Update
August 22 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal de São Paulo
São Paulo, São Paulo, Brazil, 04039-001